Agenus/LinkedIn
Apr 21, 2025, 14:44
Myriam Chalabi to present first results from NEOASIS trial on neoadjuvant BOT/BAL in MSI-H and MSS solid tumors – Agenus
Agenus shared a post on LinkedIn:
“Looking ahead to AACR25:
Dr. Myriam Chalabi will present the first results from the NEOASIS trial, evaluating neoadjuvant botensilimab/balstilimab in MSI-H and MSS solid tumors.
Learn more about the presentation.”
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29
Apr 21, 2025, 17:21